ATE233551T1 - Änderung der aktivität und/oder spiegel von häm- oxygenase zur beherrschung von entzündung - Google Patents

Änderung der aktivität und/oder spiegel von häm- oxygenase zur beherrschung von entzündung

Info

Publication number
ATE233551T1
ATE233551T1 AT95932094T AT95932094T ATE233551T1 AT E233551 T1 ATE233551 T1 AT E233551T1 AT 95932094 T AT95932094 T AT 95932094T AT 95932094 T AT95932094 T AT 95932094T AT E233551 T1 ATE233551 T1 AT E233551T1
Authority
AT
Austria
Prior art keywords
control
inflammation
levels
altering
oxygenase activity
Prior art date
Application number
AT95932094T
Other languages
English (en)
Inventor
Dean Willis
Adrian Richard Moore
Derek Albert Willoughby
Original Assignee
William Harvey Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4154382&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE233551(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by William Harvey Res Ltd filed Critical William Harvey Res Ltd
Application granted granted Critical
Publication of ATE233551T1 publication Critical patent/ATE233551T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Mirrors, Picture Frames, Photograph Stands, And Related Fastening Devices (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Rear-View Mirror Devices That Are Mounted On The Exterior Of The Vehicle (AREA)
  • Medicinal Preparation (AREA)
AT95932094T 1994-09-22 1995-09-22 Änderung der aktivität und/oder spiegel von häm- oxygenase zur beherrschung von entzündung ATE233551T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002132690A CA2132690A1 (en) 1994-09-22 1994-09-22 Control and modulation of inflammatory response in humans in need of such control and modulation
PCT/GB1995/002249 WO1996009038A2 (en) 1994-09-22 1995-09-22 Alteration of activity and/or levels of haem-oxygenase to control inflammation

Publications (1)

Publication Number Publication Date
ATE233551T1 true ATE233551T1 (de) 2003-03-15

Family

ID=4154382

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95932094T ATE233551T1 (de) 1994-09-22 1995-09-22 Änderung der aktivität und/oder spiegel von häm- oxygenase zur beherrschung von entzündung

Country Status (12)

Country Link
EP (1) EP0782441B1 (de)
JP (1) JPH10506388A (de)
CN (1) CN1213742C (de)
AT (1) ATE233551T1 (de)
AU (1) AU3528195A (de)
CA (1) CA2132690A1 (de)
DE (1) DE69529831T2 (de)
DK (1) DK0782441T3 (de)
ES (1) ES2192205T3 (de)
NZ (1) NZ292963A (de)
PT (1) PT782441E (de)
WO (1) WO1996009038A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US5756492A (en) * 1996-09-09 1998-05-26 Sangstat Medical Corporation Graft survival prolongation with porphyrins
WO1999023097A1 (en) 1997-11-03 1999-05-14 Duke University Substituted porphyrins
ES2257858T3 (es) 1998-04-24 2006-08-01 Duke University Porfirinas sustituidas.
AR024523A1 (es) 1998-12-17 2002-10-16 Sangstat Medical Corp Metodo para aumentar la sobrevida de un injerto por modulacion de la actividad de hemo oxigenasa
ATE312103T1 (de) 1999-01-25 2005-12-15 Nat Jewish Med & Res Center Substituierte porphyrine und deren therapeutische verwendungen
EP1439842A4 (de) 2001-06-01 2009-09-02 Nat Jewish Med & Res Center Oxidantienfänger zur behandlung von diabetes oder zur verwendung bei der transplantation oder induktion von immuntoleranz
NZ534912A (en) 2002-02-04 2007-08-31 Alfama Investigacao E Desenvol supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative
WO2003088748A1 (en) 2002-04-15 2003-10-30 Beth Israel Deaconess Medical Center Use of heme oxygenase-1 and products of heme degradation
US7485721B2 (en) 2002-06-07 2009-02-03 Duke University Substituted porphyrins
FR2842738B1 (fr) * 2002-07-23 2006-02-10 Negma Lerads Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus
BRPI0616448A2 (pt) * 2005-09-30 2011-06-21 Ovation Pharmaceuticals Inc método de tratar e de profilaxia de pancreatite, método de induzir gene ho e método de tratamento ex vivo de pancreatite
CN102105146A (zh) 2008-05-23 2011-06-22 国立犹太保健医院 用于治疗与暴露于烷化物质有关的损伤的方法
DK2536285T3 (en) * 2010-02-18 2018-07-16 Vtv Therapeutics Llc Substituted fused imidazole derivatives, pharmaceutical compositions and methods for their use
EP2699242B1 (de) 2011-04-19 2017-11-01 Alfama, Inc. Kohlenmonoxidfreisetzende moleküle und ihre verwendungen
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
CN105727379A (zh) * 2016-02-25 2016-07-06 顾宇春 血红素加氧酶药物洗脱支架
CN110585215B (zh) * 2019-09-19 2023-06-02 中山大学 氯化血红素及其复合物在医药中的新应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
US5102670A (en) * 1990-09-14 1992-04-07 Abraham Nader G Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
WO1992018112A1 (en) * 1991-04-19 1992-10-29 The Children's Medical Center Corporation Method of preventing nmda receptor complex-mediated neuronal damage
WO1993007114A1 (en) * 1991-09-24 1993-04-15 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
EP0673236A4 (de) * 1992-12-10 1999-07-07 Hemogen Inc Verfahren zur stimulation der produktion von häm-oxygenase unter verwendung von vitamin b12.

Also Published As

Publication number Publication date
EP0782441B1 (de) 2003-03-05
CN1213742C (zh) 2005-08-10
WO1996009038A2 (en) 1996-03-28
CN1166785A (zh) 1997-12-03
DE69529831T2 (de) 2003-12-24
JPH10506388A (ja) 1998-06-23
PT782441E (pt) 2003-07-31
CA2132690A1 (en) 1996-03-23
EP0782441A1 (de) 1997-07-09
WO1996009038A3 (en) 1996-06-13
ES2192205T3 (es) 2003-10-01
AU3528195A (en) 1996-04-09
NZ292963A (en) 2001-06-29
DE69529831D1 (de) 2003-04-10
DK0782441T3 (da) 2003-06-30

Similar Documents

Publication Publication Date Title
ATE233551T1 (de) Änderung der aktivität und/oder spiegel von häm- oxygenase zur beherrschung von entzündung
ATE135231T1 (de) Verwendung von ''cartilage-inducing factor'' (cif) zur behandlung von hemato- oder lymphopoietischen krankheiten
DE3584172D1 (de) 17-beta-substituierte-4-aza-5-alpha-androstenone und ihre anwendung als 5-alpha-reduktase-inhibitoren.
DE69837295D1 (de) Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1
ES2092460T3 (es) Composicion dadora de oxido nitrico para el tratamiento de trastornos anales.
NO20002440L (no) Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
ATE20185T1 (de) Mittel zur verhuetung und behandlung von leberund nierenkrankheiten.
DE69205859D1 (de) Verwendung von oberflächenaktiven Mitteln zur Verbesserung des Rückflusses von Venenkathetern.
DE69620458D1 (de) Benzofuran-carboxamide und -sulfonamide
DK71387A (da) Terapeutisk middel til behandling af psoriasis
ATE471985T1 (de) Protease from lucilia sericata und deren verwendung zur wundheilung
DE3584974D1 (de) Zusammensetzungen von ungesaettigten polyestern oder polyesteramiden mit polycycloalkenylendgruppen und vinylaktive plastifiziermittel dazu.
ATE209891T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis
ATE206052T1 (de) Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
DE3679781D1 (de) Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung.
ATE117549T1 (de) Lysyl-oxidase-inhibitoren.
ATE354591T1 (de) Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen
EE9700350A (et) COMT-inhibiitorite uus kasutamine ja diabeetiliste vaskulaarsete häirete ärahoidmise meetod
FI844020L (fi) Framstaellning av diarylindan-1,3-dioner och anvaendning av dessa.
DE3674619D1 (de) Zusammensetzung fuer baeder auf basis von psoralen in der behandlung von psoriasis.
ES2161293T3 (es) Derivados de enol acilados como profarmacos de inhibidores de la elastasa.
ATE48132T1 (de) Isoxazol- und isothiazolderivate.
KR890701732A (ko) 개량형 조직 플라스미노겐 활성화 인자
ATE141617T1 (de) Kontinuierliche hydrolyse von zelluloseacetat
ATE142878T1 (de) Verwendung der 3-indolbrenztraubensäure zur erniedrigung der glucocorticoidblutspiegel und zur vorbeugung cerebraler störungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0782441

Country of ref document: EP

RZN Patent revoked